Yonggui Wu

4.1k total citations
101 papers, 2.4k citations indexed

About

Yonggui Wu is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Yonggui Wu has authored 101 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Nephrology, 34 papers in Molecular Biology and 29 papers in Immunology. Recurrent topics in Yonggui Wu's work include Chronic Kidney Disease and Diabetes (25 papers), Renal Diseases and Glomerulopathies (15 papers) and Advanced Glycation End Products research (12 papers). Yonggui Wu is often cited by papers focused on Chronic Kidney Disease and Diabetes (25 papers), Renal Diseases and Glomerulopathies (15 papers) and Advanced Glycation End Products research (12 papers). Yonggui Wu collaborates with scholars based in China, United States and Germany. Yonggui Wu's co-authors include Xiangming Qi, Xingxin Xu, Xue‐qi Liu, Ling Jiang, Xiao‐Ming Meng, Jijia Shen, Lingling Xia, Li Gao, Yuebo Huang and Han-xu Zeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

Yonggui Wu

94 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonggui Wu China 31 1.1k 657 416 367 282 101 2.4k
Ya‐Long Feng China 23 1.5k 1.3× 579 0.9× 220 0.5× 229 0.6× 452 1.6× 33 3.0k
Liyu He China 27 1.3k 1.2× 1.2k 1.8× 370 0.9× 230 0.6× 239 0.8× 93 3.1k
Adrián M. Ramos Spain 30 1.3k 1.1× 870 1.3× 430 1.0× 335 0.9× 328 1.2× 62 3.0k
Guixia Ding China 25 937 0.9× 633 1.0× 157 0.4× 192 0.5× 157 0.6× 68 2.0k
Dae Ryong South Korea 32 1.1k 1.0× 777 1.2× 307 0.7× 141 0.4× 239 0.8× 93 3.1k
Ming‐Zhi Zhang United States 38 1.5k 1.4× 855 1.3× 433 1.0× 283 0.8× 386 1.4× 83 4.1k
Jay C. Jha Australia 21 902 0.8× 599 0.9× 460 1.1× 241 0.7× 132 0.5× 38 2.5k
Yanggang Yuan China 26 1.1k 1.0× 771 1.2× 124 0.3× 157 0.4× 181 0.6× 86 2.3k
Yachun Han China 25 1.0k 1.0× 549 0.8× 169 0.4× 175 0.5× 178 0.6× 58 2.1k

Countries citing papers authored by Yonggui Wu

Since Specialization
Citations

This map shows the geographic impact of Yonggui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonggui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonggui Wu more than expected).

Fields of papers citing papers by Yonggui Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonggui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonggui Wu. The network helps show where Yonggui Wu may publish in the future.

Co-authorship network of co-authors of Yonggui Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yonggui Wu. A scholar is included among the top collaborators of Yonggui Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonggui Wu. Yonggui Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Jie, Qi Deng, Wei Lin, et al.. (2025). Inhibition of GRK2 mitigates renal fibrosis via oxidative stress pathway. European Journal of Pharmacology. 1003. 177887–177887.
2.
Wang, Ying, Renwu Zhou, Xiaoxia Wang, et al.. (2024). Baseline fibroblast growth factor 23 predicts incident heart failure and cardiovascular mortality in patients with chronic kidney disease: A 3-year follow-up study. IJC Heart & Vasculature. 56. 101587–101587. 1 indexed citations
3.
Wang, Qianhui, et al.. (2024). Diagnostic value of TRIM22 in diabetic kidney disease and its mechanism. Endocrine. 87(3). 959–977. 1 indexed citations
4.
Jiang, Ling, et al.. (2024). Rutaecarpine protects podocytes in diabetic kidney disease by targeting VEGFR2/NLRP3-mediated pyroptosis. International Immunopharmacology. 130. 111790–111790. 6 indexed citations
5.
Guo, Shanshan, Lang Zhou, Xueqi Liu, et al.. (2024). Baicalein alleviates cisplatin-induced acute kidney injury by inhibiting ALOX12-dependent ferroptosis. Phytomedicine. 130. 155757–155757. 24 indexed citations
6.
Zhang, Jinyu, et al.. (2024). Downregulation of CD36 alleviates IgA nephropathy by promoting autophagy and inhibiting extracellular matrix accumulation in mesangial cells. International Immunopharmacology. 144. 113672–113672. 1 indexed citations
7.
Wang, Meixi, et al.. (2024). Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease. Renal Failure. 46(1). 2313182–2313182. 3 indexed citations
8.
Wang, Lin, et al.. (2023). Integrated Analysis of Ferroptosis and Immunity-Related Genes Associated with Diabetic Kidney Disease. Diabetes Metabolic Syndrome and Obesity. Volume 16. 3773–3793. 3 indexed citations
9.
Wu, Yonggui, et al.. (2023). Ambient air pollution exposure and telomere length: a systematic review and meta-analysis. Public Health. 215. 42–55. 14 indexed citations
10.
Wang, Huaying, Shanshan Guo, Xueqi Liu, et al.. (2023). Carnosine attenuates renal ischemia–reperfusion injury by inhibiting GPX4-mediated ferroptosis. International Immunopharmacology. 124(Pt A). 110850–110850. 9 indexed citations
11.
12.
Liu, Xueqi, Mengya Zhang, Lang Zhou, et al.. (2023). Paeoniflorin alleviates ischemia/reperfusion induced acute kidney injury by inhibiting Slc7a11-mediated ferroptosis. International Immunopharmacology. 116. 109754–109754. 32 indexed citations
13.
Jiang, Ling, Xue‐qi Liu, Li Gao, et al.. (2022). METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Molecular Therapy. 30(4). 1721–1740. 135 indexed citations
14.
Huang, Yuebo, Ling Jiang, Xue‐qi Liu, et al.. (2022). Melatonin Alleviates Acute Kidney Injury by Inhibiting NRF2/Slc7a11 Axis‐Mediated Ferroptosis. Oxidative Medicine and Cellular Longevity. 2022(1). 4776243–4776243. 51 indexed citations
15.
Yu, Ju-tao, Xiaowei Hu, Haiyong Chen, et al.. (2020). DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-α in alcohol-induced kidney injury. Pharmacological Research. 163. 105286–105286. 64 indexed citations
16.
Wang, Jianan, Mingming Liu, Fang Wang, et al.. (2019). RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress. Clinical Science. 133(14). 1609–1627. 67 indexed citations
17.
Xu, Xingxin, et al.. (2016). The role of TGF-β-activated kinase 1 in db/db mice and high glucose-induced macrophage. International Immunopharmacology. 38. 120–131. 10 indexed citations
18.
Qi, Xiangming, et al.. (2015). FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats. Inflammation Research. 65(2). 103–114. 30 indexed citations
19.
Chen, Maosheng, et al.. (2014). Leonurine ameliorates LPS-induced acute kidney injury via suppressing ROS-mediated NF-κB signaling pathway. Fitoterapia. 97. 148–155. 95 indexed citations
20.
Tang, Zheng, Yonggui Wu, Weixin Hu, et al.. (2001). The distribution and significance of renal infiltrating cells in patients with diffuse crescentic glomerulonephritis.. PubMed. 114(12). 1267–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ya‐Long Feng Breakdown of academic impact, for papers by Liyu He Breakdown of academic impact, for papers by Adrián M. Ramos Breakdown of academic impact, for papers by Guixia Ding Breakdown of academic impact, for papers by Dae Ryong Breakdown of academic impact, for papers by Ming‐Zhi Zhang Breakdown of academic impact, for papers by Jay C. Jha Breakdown of academic impact, for papers by Yanggang Yuan Breakdown of academic impact, for papers by Yachun Han
Rankless by CCL
2026